4.57
price up icon2.24%   0.10
after-market Dopo l'orario di chiusura: 4.57
loading

Lixte Biotechnology Holdings Inc Azioni (LIXT) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
9.60%
0.7748
0.7069 0.6135 0.9833 1.0092
Interest Income/Expense
42.26%
0.00181
0.00314 0.00443 0.00105 0.00415
Operating Income/Loss
9.60%
-0.7748
-0.7069 -0.6135 -0.9833 -1.0092
Income/Loss From Continuing Operations Before Tax
9.32%
-0.7757
-0.7096 -0.6177 -0.986 -1.0109
Income/Loss From Continuing Operations After Tax
9.32%
-0.7757
-0.7096 -0.6177 -0.986 -1.0109
Net Income/Loss
9.32%
-0.7757
-0.7096 -0.6177 -0.986 -1.0109
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
10.08%
2.7205
2.4715 - 2.2493 2.2493
Diluted Average Shares
10.08%
2.7205
2.4715 - 2.2493 2.2493
Basic Earnings Per Share
0.00%
-0.29
-0.29 -0.27 -0.44 -0.45
Diluted Earnings Per Share
0.00%
-0.29
-0.29 -0.27 -0.44 -0.45
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Capitalizzazione:     |  Volume (24 ore):